These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

193 related items for PubMed ID: 2765997

  • 1. [New elements in the diagnosis and treatment of thyrotropic pituitary adenomas with hyperthyroidism].
    Linquette M, Cappoen JP, Mazzuca M.
    Bull Acad Natl Med; 1989 Feb; 173(2):217-20; discussion 221-2. PubMed ID: 2765997
    [Abstract] [Full Text] [Related]

  • 2. Long-term preoperative management of thyrotropin-secreting pituitary adenoma with octreotide.
    Iglesias P, Díez JJ.
    J Endocrinol Invest; 1998 Dec; 21(11):775-8. PubMed ID: 9972679
    [Abstract] [Full Text] [Related]

  • 3. TSH-secreting pituitary macroadenoma: rapid tumor shrinkage and recovery from hyperthyroidism with octreotide.
    Fischler MP, Reinhart WH.
    J Endocrinol Invest; 1999 Jan; 22(1):64-5. PubMed ID: 10090139
    [Abstract] [Full Text] [Related]

  • 4. Effect of octreotide acetate on thyrotropin-secreting adenoma: report of two cases and review of the literature.
    Yoenem A, Cakyr B, Azal O, Corakcy A, Kutlu M, Oezata M.
    Endocr Regul; 1999 Dec; 33(4):169-74. PubMed ID: 10700085
    [Abstract] [Full Text] [Related]

  • 5. Criteria of cure and follow-up of central hyperthyroidism due to thyrotropin-secreting pituitary adenomas.
    Losa M, Giovanelli M, Persani L, Mortini P, Faglia G, Beck-Peccoz P.
    J Clin Endocrinol Metab; 1996 Aug; 81(8):3084-90. PubMed ID: 8768879
    [Abstract] [Full Text] [Related]

  • 6. [Thyrotropin-secreting pituitary adenomas].
    Caron P.
    Presse Med; 2009 Jan; 38(1):107-11. PubMed ID: 18980829
    [Abstract] [Full Text] [Related]

  • 7. A thyrotropin-secreting pituitary adenoma as a cause of thyrotoxic periodic paralysis.
    Alings AM, Fliers E, de Herder WW, Hofland LJ, Sluiter HE, Links TP, van der Hoeven JH, Wiersinga WM.
    J Endocrinol Invest; 1998 Nov; 21(10):703-6. PubMed ID: 9854688
    [Abstract] [Full Text] [Related]

  • 8. Efficacy of the long-acting octreotide formulation (octreotide-LAR) in patients with thyrotropin-secreting pituitary adenomas.
    Caron P, Arlot S, Bauters C, Chanson P, Kuhn JM, Pugeat M, Marechaud R, Teutsch C, Vidal E, Sassano P.
    J Clin Endocrinol Metab; 2001 Jun; 86(6):2849-53. PubMed ID: 11397898
    [Abstract] [Full Text] [Related]

  • 9. Absence of receptors for thyrotropin (TSH)-releasing hormone in human TSH-secreting pituitary adenomas associated with hyperthyroidism.
    Chanson P, Li JY, Le Dafniet M, Derome P, Kujas M, Murat A, Charpentier G, Racadot J, Peillon F.
    J Clin Endocrinol Metab; 1988 Feb; 66(2):447-50. PubMed ID: 2828411
    [Abstract] [Full Text] [Related]

  • 10. [Octreotide in the diagnosis and treatment of pituitary thyrotropin-secreting adenoma].
    Chen S, Li M, Lian XL, Zeng ZP, Dai WX, Li F, Yu W, Wang RZ.
    Zhonghua Nei Ke Za Zhi; 2006 Nov; 45(11):910-3. PubMed ID: 17313878
    [Abstract] [Full Text] [Related]

  • 11. Thyrotropin-secreting pituitary adenomas: report of seven cases.
    Beckers A, Abs R, Mahler C, Vandalem JL, Pirens G, Hennen G, Stevenaert A.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):477-83. PubMed ID: 1704011
    [Abstract] [Full Text] [Related]

  • 12. [Effect of long-term treatment with octreotide-lar in a TSH-secreting pituitary macroadenoma and secondary hyperthyroidism].
    Del Monte P, Bernasconi D, Ruelle A, Marugo A, Marugo M, Torre R.
    Minerva Endocrinol; 2005 Jun; 30(2):95-9. PubMed ID: 15988405
    [Abstract] [Full Text] [Related]

  • 13. [Thyrotropin--TSH secreting pituitary tumor].
    Zieliński G, Podgórski JK, Warczyńska A, Koziarski A, Zgliczyński W.
    Przegl Lek; 2002 Jun; 59(12):1018-23. PubMed ID: 12731380
    [Abstract] [Full Text] [Related]

  • 14. Hyperthyroidism due to a pituitary adenoma composed of two different cell types, one secreting alpha-subunit alone and another cosecreting alpha-subunit and thyrotropin.
    Terzolo M, Orlandi F, Bassetti M, Medri G, Paccotti D, Cortelazzi D, Angeli A, Beck-Peccoz P.
    J Clin Endocrinol Metab; 1991 Feb; 72(2):415-21. PubMed ID: 1704010
    [Abstract] [Full Text] [Related]

  • 15. Hyperthyroidism due to a thyrotropin-secreting pituitary adenoma. Studies of thyrotropin and subunit secretion.
    Smith CE, Smallridge RC, Dimond RC, Wartofsky L.
    Arch Intern Med; 1982 Sep; 142(9):1709-11. PubMed ID: 6810781
    [Abstract] [Full Text] [Related]

  • 16. Effect of a long-acting somatostatin analogue (SMS 201-995) on a growth hormone and thyroid stimulating hormone-producing pituitary tumor.
    Hirasawa R, Hashimoto K, Makino S, Suemaru S, Takao T, Ota Z, Hoshida Y, Yoshino T, Akagi T.
    Acta Med Okayama; 1991 Apr; 45(2):107-15. PubMed ID: 1867112
    [Abstract] [Full Text] [Related]

  • 17. Ectopic Suprasellar Thyrotropin-Secreting Pituitary Adenoma: Case Report and Literature Review.
    Wang Q, Lu XJ, Sun J, Wang J, Huang CY, Wu ZF.
    World Neurosurg; 2016 Nov; 95():617.e13-617.e18. PubMed ID: 27567574
    [Abstract] [Full Text] [Related]

  • 18. [Hyperthyroidism caused by a TSH producing pituitary adenoma].
    Prasch F, Knosp SE, Steinbach R, Wogritsch S, Hurtl I, Greifeneder M, Holm C, Najemnik C, Dudczak R.
    Acta Med Austriaca; 1999 Nov; 26(1):32-6. PubMed ID: 10230475
    [Abstract] [Full Text] [Related]

  • 19. Different responses to chronic somatostatin analogues in patients with central hyperthyroidism.
    Mannavola D, Persani L, Vannucchi G, Zanardelli M, Fugazzola L, Verga U, Facchetti M, Beck-Peccoz P.
    Clin Endocrinol (Oxf); 2005 Feb; 62(2):176-81. PubMed ID: 15670193
    [Abstract] [Full Text] [Related]

  • 20. [Hyperthyroidism caused by TSH producing hypophyseal adenoma].
    Pichler R, Hatzl M, Huber H, Maschek W, Myslivecek M, Mustafa H, Drlicek M.
    Wien Klin Wochenschr; 1997 Apr 25; 109(8):281-5. PubMed ID: 9221605
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.